A new method to treat acute myeloid leukemia uses the gene editing tool CRISPR/Cas9 to remove CD33 from healthy blood-forming stem cells, leaving the cancerous cells as the only targets left for the CD33 hunter cells to attack.
from Medindia Health News https://ift.tt/2sqO8My
No comments:
Post a Comment